Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 107, 179-181
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled studyThe Lancet Respiratory Medicine, 2020
- Co-infections in people with COVID-19: a systematic review and meta-analysisJournal of Infection, 2020
- Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?Journal of Microbiology, Immunology and Infection, 2020
- Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 DetectionJournal of Clinical Microbiology, 2020
- Multiplex PCR implementation as point-of-care testing in a French emergency departmentJournal of Hospital Infection, 2020
- Multicenter Evaluation of QIAstat-Dx Respiratory Panel V2 for Detection of Viral and Bacterial Respiratory PathogensJournal of Clinical Microbiology, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020